 effect intravesical bacillus Calmette-Guerin therapy upper urinary tract total patients low grade low stage transitional cell carcinoma bladder intravesical bacillus Calmette-Guerin BCG underwent cystourethrography vesicoureteral reflux BCG instilled weekly weeks monthly thereafter months vesicoureteral reflux morphological abnormalities excretory urography IVP isotope renal scan relative renal function Vesicoureteral reflux patients grades reflux number BCG instillations IVPs normal patients patients mild unilateral dilatation present BCG instillations unchanged therapy None patients vesicoureteral reflux IVP features urinary tuberculosis patients renal systems normal relative renal function patients decrease relative renal function normal IVPs nonBCG cause BCG therapy safe patients minimal reflux